I am a Clinician-Scientist-Educator as a Geriatric Neurologist with a long-standing commitment to advancing neuroscience research, mentoring the next generation of investigators, and translating scientific insights into clinical impact. For two decades, I explored hippocampal sclerosis, its circuit plasticity and consequential epileptogenesis. However, over the past decade, I have increasingly focused on neurodegenerative diseases and the systems-level mechanisms underlying dementia. My ongoing collaborative work integrates my expertise in clinical neurophysiology, brain circuitry, and translational research into the field of Alzheimer’s disease (AD), specifically within multi-omics and APOE-related projects. I see patients with these conditions in my geriatric neurology clinic. Given my passion for remaining a triple-threat academic physician scientist, I couldn’t pass up the opportunity of becoming the Director of our MD/PhD Program and mentoring 60-70 future clinician scientists at any one time. For the past 14 years, I have been responsible for recruitment, admissions, curriculum, mentoring, student affairs, financials, and development within the Graduate and Medical School Dean’s offices as it pertains to the MD/PhD Program. I have successfully mentored 57 students to earn their PhD degrees in this program and 45 with both degrees. I have also served as our CTSA KL2 Program Director for 2014-2018 and the REC Leader for our South Texas ADRC since 2021. Overall, I have mentored over 130 MD/PhD students in my career and supervised the career development of 34 KL2 mentored junior research faculty, 5 neurology junior faculty, and 37 clinical neurophysiology fellows. Several of my trainees have successfully obtained independent research funding as investigators and/or received NIH-K23, K08, K01, and other research awards. I also co-founded a company that develop a convulsive seizure detector and was the PI of four clinical studies including a pivotal multicenter double-blinded study that led to FDA de-novo 510(k) clearance in 2017. I am deeply passionate about clinician scientist training and improving the efficienty of our current training systems to allow for richer interactions between the bench and the bedside.